Treosulfan
Overview
Treosulfan is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL455186).
API suppliers (2)
Suppliers of Treosulfan evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
1 of 2 holds a GMP certificate on record in the EU or UK registers
- FERMION OYFinland1 active DMF GMP on record
- MEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATE MBHFrance1 active DMF
Patent & exclusivity (US)
Per the FDA Orange Book (2 approved US products), the latest listed US patent on Treosulfan expires 12 Oct 2026 and exclusivity 21 Jan 2032. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- [(2S,3S)-2,3-dihydroxy-4-methylsulfonyloxybutyl] methanesulfonate
- Canonical SMILES
- CS(=O)(=O)OC[C@@H]([C@H](COS(=O)(=O)C)O)O
- InChIKey
- YCPOZVAOBBQLRI-WDSKDSINSA-N
Do you supply Treosulfan? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.